Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label IGF-I study in degenerative cerebellar ataxia
2010-019737-94Phase 4Active
- Sponsor
- FIBHULP
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mecasermin in Degenerative cerebellar ataxia, sponsored by FIBHULP. Primary endpoints: Change in cerebellar impairment by SARA, MRI morphometric change and 3 more. Started Mar 2010; status: active.
02
Drugs
mecasermin
03
Conditions
Degenerative cerebellar ataxia
Beyond the preview
Go deeper on 2010-019737-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019737-94.